Abstract
Vibrio parahaemolyticus carrying binary toxin genes, pirAB, is one of the etiological agents causing acute hepatopancreatic necrosis disease (AHPND) in shrimp. This disease has emerged recently as a major threat to shrimp aquaculture worldwide. During a routine PCR screening of AHPND-causing V. parahaemolyticus strains, an isolate tested PCR positive for pirB (R13) and another isolate tested positive for both the pirA and pirB (R14) genes. To evaluate the pathogenicity of these isolates, specific pathogen-free (SPF) Penaeus vannamei were experimentally challenged. For both R13 and R14 isolates, the final survival rate was 100% at termination of the challenge, whereas the final survival with the AHPND-causing V. parahaemolyticus was 0%. The nucleotide sequence of the plasmid DNA carrying the binary toxin genes revealed that R13 contains a deletion of the entire pirA gene whereas R14 contains the entire coding regions of both pirA and pirB genes. However, R14 possesses an insertion upstream of the pirA gene. In R14, mRNA for both pirA and pirB genes could be detected but no cognate proteins. This shows that the genome of AHPND-causing V. parahaemolyticus is highly plastic and, therefore, detection of the pirA and pirB genes alone by DNA-PCR is insufficient as a diagnostic test for AHPND.
Keywords: acute hepatopancreatic necrosis disease, Early Mortality Syndrome, shrimp, diseases
1. Introduction
Since 2009, acute hepatopancreatic necrosis disease (AHPND), also known as “Early Mortality Syndrome (EMS)”, has caused significant production losses in many South East (SE) Asian countries, including China, Vietnam, Malaysia, Thailand [1,2] and the Philippines [3]. In 2013, the presence of AHPND was confirmed in the Western Hemisphere, particularly in Mexico [4], and in 2017 in the US [5]. In recent years, there have been some studies that suggest the presence of AHPND in other countries in Central America [6] and South America [7,8]. This emerging disease has caused an estimated loss of USD 15.0 billion in shrimp aquaculture worldwide (D.V. Lightner, pers. communication). Due to its rapid spread, AHPND is now posing a serious threat to shrimp farming globally.
The causative agents of AHPND were determined to be distinct strains of bacteria, including Vibrio parahaemolyticus [2,9], V campbellii [10] V. harveyi [11], V. owensii [12] and V. punensis [8], that contain a binary toxin, PirABvp, and the PirA and PirB toxins have been confirmed as the virulence factor of the disease. The pirABvp genes are located in a large plasmid (69–70 kb) within a 3.5-kb fragment flanked by transposes that could be involved in insertion and deletion events causing mutations in the pirAB region that might affect the pathogenicity of AHPND Vibrio strains [9,12,13,14].
AHPND usually appears during the first 20 to 30 days of culture, causing up to 100% mortality in severe cases; however, some reports indicate that juveniles of Penaeus vannamei and Penaeus monodon of sizes between 6–15 g can be also affected [3]. In the acute phase, the infected hepatopancreas (HP) shows tubule epithelial degeneration and round up and detachment of tubule epithelial cells from the basal membrane. This leads to the sloughing of epithelial cells into the tubule lumen. In the terminal stage, the hepatopancreas shows extensive inter-tubular, hemocytic aggregations which cause hepatopancreas dysfunction and a severe secondary Vibrio spp. infection [1,2]. In recent studies, a new phase of AHPND was described, the chronic phase, characterized by the presence of a granulomatous response in the HP tubules accompanied by bacteria and resembling septic hepatopancreatic necrosis (SHPN) [15].
In this study, we found two novel mutants that tested positive for one or both toxin genes (pirA and pirB) by the World Organization for Animal Health (OIE)-approved PCR method but did not cause AHPND in experimental bioassays, even when the bacterial isolate (R14) contained both toxin genes. The findings revealed that the genome of V. parahaemolyticus that cause AHPND is highly plastic, and this has implications in the disease manifestation and diagnosis of AHPND in shrimp using PCR-based diagnostic tools.
2. Materials and Methods
2.1. Wild Type and Natural Mutants of AHPND-Causing V. parahaemolyticus
Four V. parahaemolyticus isolates from the University of Arizona Aquaculture Pathology Laboratory were used in this study. Vibrio parahaemolyticus 13-028/A3 (A3), an AHPND-causing strain which was isolated from AHPND-affected shrimp in Vietnam [2], was used as a VPAHPND reference strain. In addition, two V. parahaemolyticus isolates, R13 and R14, originating from a Latin American country that tested positive by PCR for pirB only (R13) or both pirAB (R14), and a human clinical V. parahaemolyticus strain obtained from the American Type Culture Collection (ATCC strain) that does not contain the toxin genes pirAB were used in the bioassay. The ATCC strain served as a negative control for the assay. Bacterial identifications were carried out using 16S rRNA sequencing [16] and Vibrio-specific PCR assays targeting the toxR gene [17]. These bacteria were grown on Tryptic soy broth with 2% NaCl (TSB+) at 28–29 °C in a shaker incubator (at 100 rpm for 24 h) prior to the immersion challenge. Bacterial genomic DNA was extracted using the Qiagen DNeasy Kit and following the manufacturer’s protocol (Hilden, Germany).
2.2. Duplex PCR Assay for the Detection of pirA- and pirB-Genes
The pirA and pirB genes were detected by duplex PCR using PuReTaq ready-to-go PCR beads. The primers used were VpPirA-284F TGA CTA TTC TCA CGA TTG GAC TG/R VpPirA-284R CAC GAC TAG CGC CAT TGT TA that amplifies a 284 bp amplicon of the pirA gene and VpPirB-392F VpPirB-392F TGA TGA AGT GAT GGG TGC TC/R VpPirB-392R TGT AAG CGC CGT TTA ACT CA that amplifies a 392 bp region of the pirB gene. Amplifications were performed with the following parameters: an initial denaturation at 94 °C for 3 min, followed by 35 cycles of 94 °C for 30 s, 60 °C for 30 s and 72 °C for 30 s, and a final extension at 72 °C for 7 min [18]. Following PCR, an aliquot of the PCR products was analyzed in a 1.5% gel containing 1 × gel red (Biotium, Fremont, CA, USA), and the gel was photographed using a BIORAD Gel Doc XR+ imaging system (BioRad, Hercules, CA, USA).
2.3. Reverse Transcriptase-PCR for the Detection of the pirAB Genes
Total bacterial RNA was extracted from an overnight culture of each bacterial isolate using the RNAzol kit (Molecular Research Center, Houston, TX, USA) and treated with Ambion DNase I (Thermo Fisher Scientific, Waltham, MA, USA) before carrying out cDNA synthesis using the Superscript IV first strand synthesis system (Thermo Fisher Scientific, Waltham, MA, USA). The cDNA was used in the duplex PCR for the detection of pirA and pirB-like genes, as described above [18].
2.4. AHPND Challenge Test
Specific pathogen-free (SPF) P. vannamei purchased from a commercial vendor in the US were used for the AHPND challenge tests. The AHPND experimental challenge was conducted to determine the pathogenicity of V. parahaemolyticus isolates, R13 and R14. The reference strain VPAHPND (A3) was used as a positive control for the bioassay. The challenge was conducted using eight 3-L tanks and artificial seawater (salinity of 25 ppt at 28 °C). Three SPF P. vannamei (average weight 7.1 g) were stocked in each jar and two jars were used for each bacterial isolate. Animals were challenged by immersion with V. parahaemolyticus R13, V. parahaemolyticus R14, V. parahaemolyticus ATCC and VPAHPND following a published protocol [10]. An overnight culture broth was added into the jars to obtain a final concentration of 5.5 × 105 CFU mL−1. Initial survival was defined by the total number of shrimp present in the tank prior to the AHPND challenge. Mortality was recorded daily from the start of the experiment and moribund shrimp were fixed in Davidson’s alcohol-formalin-acetic acid (AFA) fixative for histopathological analysis [19]. Samples of the dead shrimp were collected to determine the presence of AHPND by PCR. All survivors were fixed at the end of the challenge for histopathological analysis. The duration of the assay was 6 days.
2.5. Histopathology
The Davidson’s alcohol-formalin-acetic acid (AFA)-fixed samples were processed, embedded in paraffin and sectioned (4 μm thick) in accordance with standard methods [19]. After staining with hematoxylin and eosin (H&E), the sections were analyzed by light microscopy. Infection severity was scored from Grade 0 to Grade 4 (G0–G4) according to Lightner (1996), with G0 being the absence of the disease and G4 indicating the presence of severe lesions and advanced tissue destruction. In the case of lipid droplets in hepatopancreas, the same grading system was used with G0–G1 being an absence and/or very few lipid droplets, respectively, and G3 and G4 indicate a high content of lipid droplets.
2.6. Sequence Analysis
The plasmid DNA sequence containing the binary toxin genes pirAB in the AHPND reference strain A3 (GenBank KM067908), V. parahaemolyticus R13 (GenBank CP028346) and V. parahaemolyticus R14 (GenBank CP028145.1) were taken for sequence analyses. A 5.5 kb region carrying the pirAB genes located in the plasmid pVPA3-1, R13 and R14 were analyzed to determine potential transposases (IS finder: http://www-is.biotoul.fr). Putative promoter regions and transcription termination sites were predicted by the Bacterial Promoter Prediction Program (BPROM) (http://www.softberry.com/cgi-bin/programs/gfindb/bprom.pl) and ARNold (http://rna.igmors.u-psud.fr/toolbox/arnold/index.php) web tools, respectively.
To identify the extent of pirAB deletion in R13, we cloned and sequenced the corresponding region from the plasmid pVpR13_71Kb of the R13 strain. The amplification was performed using forward primer, A3-15554-FP (15,554–15,574 position of pVPA3-1 sequence 5’-CTT GTA TCT ACC GCG ATA TGC-3’) and reverse primer, pirBFull-1RP (18,862–18,837 position of pVPA3-1 sequence 5’- CTA CTT TTC TGT ACC AAA TTC ATC GG-3’). The PCR product was cloned in a TOPOTM cloning vector, pCR2.1TM. The insert was sequenced in both directions and the sequence was deposited into the NCBI database with the accession number MK368635. To identify the insertion sequence in R14, the forward primer R14-66011F (nucleotide positions 66,011 to 66,028 in pVpR14_74Kb plasmid): 5’-CTT CAA GCG TCC CAT TCG-3’ and reverse primer pirA-240R (nucleotide positions 68,018 to 67,997 in pVpR14_74Kb plasmid): 5’-TTT CAT CAC GTT GTA CCA CAT G-3’ were used to clone a fragment that included upstream of the coding region of the pirA gene through 240 bp 5’-end of the coding region of pirA gene. The amplicon was cloned in a TOPO pCR2.1 vector and sequenced in both directions and the sequence was submitted to the NCBI (accession number MK368636).
2.7. Western Blot Analysis
To detect binary toxins PirA and PirB that cause AHPND by Western blot analysis, V. parahaemolyticus ATCC, A3, R13 and R14 were grown in the TSB+ medium for 24 h. Total protein was extracted from the whole culture following previous publication [20]. The total protein was separated on an kilodalton (kD)precast SDS-PAGE gel (BioRad) using a running buffer (25 mM Tris, pH 8.3, 192 mM glycine, 0.1% SDS) at 80 V for 1 h. The proteins present in the gel were transferred onto a nitrocellulose membrane at 1mA/cm2. Western blot analysis was conducted following a published protocol [20]. Anti-PirA and -PirB monoclonal (GenScript Biotech) antibodies at a concentration of 1:5000 were used. In addition, an anti- Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) monoclonal antibody (Abcam®, UK) was used to detect GAPDH, a loading control, the molecular mass of which varies between 35 and 37 kDa depending on bacterial isolates.
3. Results
3.1. Duplex PCR for the Detection of the pirA and pirB-Like Genes
Figure 1 shows the amplification of the pirA and pirB genes by DNA PCR using total genomic DNA of V. parahaemolyticus isolates from Latin America. In the V. parahaemolyticus reference strain (A3), amplicons of 284 bp (pirA) and 392 bp (pirB) were detected. In the isolate R13, only the amplicon corresponding to pirB (392 bp) was detected, whereas in R14, both pirA and pirB genes were successfully detected.
3.2. Challenge Test, Histopathology and PCR Results
The experimental challenge using the V. parahaemolyticus reference strain A3 resulted in 100% mortality of the SPF shrimp at 1 day post-challenge. However, no mortalities were recorded in animals challenged with either R13, R14 or V. parahaemolyticus ATCC strains (Figure 2). Dorsoventral sectioning of the cephalothorax of healthy and bacterial challenged shrimp is shown in Figure 3. Hepatopancreas samples from R13, R14 and A3 showed different discoloration patterns. Shrimp infected with the A3 strain showed clinical signs characteristics of AHPND, including pale discoloration and atrophy of hepatopancreas (Figure 3b). In contrast, animals challenged with R13, R14 and ATCC V. parahaemolyticus strains did not show any clinical signs and hepatopancreas did not display any discoloration or atrophy in the challenged animals. In deceased animals challenged with A3, both pirA and pirB genes could be amplified by duplex PCR. In R14, both pirA and pirB genes could be amplified by duplex PCR from challenged shrimp. In the R13 strain, only pirB and not the pirA gene could be amplified, while in V. parahaemolyticus ATCC strain, neither of the toxin genes could be amplified.
Histopathology of shrimp challenged with VPAHPND A3 showed lesions typical of AHPND in the acute phase, including multifocal necrosis and massive sloughing of hepatopancreatic tubule epithelial cells in the medial region of the hepatopancreas and progressing outward to the distal region (Figure 4C). However, in the shrimp exposed to R13, R14 or VP, no lesions that are characteristic of AHPND were observed. High levels of vacuolization (G3) in the hepatopancreatic tubule were observed in all the examined shrimp. Although there are no apparent lesions in the shrimp challenged with the R13 and R14 strains, the hepatopancreatic tubules in the shrimp challenged with R13 look smaller than those in the shrimp challenged with the R14 strain. This could have been due to the sectioning of the HP tubule in a region closest to the apical end on the shrimp exposed to the R13 strain that tend to be smaller than other sections close to the proximal end.
3.3. Detection of pirA and pirB Transcripts by RT-PCR
The binary toxin genes pirA and pirB were detected in shrimp challenged with R14 strains, while only the pirB gene was detected in the shrimp challenged with R13 (Figure 1). To further confirm that the toxin genes are not expressed, total RNA was extracted and cDNA was used to perform RT-PCR to amplify the pirA and pirB genes. A photomicrograph of an agarose gel showing cDNA amplicons representing the binary toxin genes amplified by duplex RT-PCR is presented in Figure 5. The pirA and pirB genes could not be amplified by RT-PCR in R13; meanwhile, R14 and A3 strains displayed expression of the toxin genes (Figure 5).
3.4. Sequence Analyses
The genetic features of the plasmid DNA carrying the binary toxin genes in the V. parahaemolyticus reference strain A3 and the mutant strains R13 and R14 are summarized in Table 1 and Figure 6. In the putative promoter region upstream of the pirAB genes in the R13 strain, there is a deletion which included the entire predicted promoter region. In contrast, the R14 strain contains the computationally predicted promoter region containing a -10 (AGTTAACAT) and a -35 (TTTCCT) at the nucleotide positions 66,586 and 66,568 bp, respectively, with reference to the GenBank entry CP28145.1 [21]. Both strains R13 and R14 contain a putative transcription termination site potentially forming a stem-loop secondary structure (stem sequence, AACCGTCC, and the loop being, ATTA) (Figure 7).
Table 1.
Genetic Features | R13 | R14 | V.P (ATCC) | A3 | XN87 * |
---|---|---|---|---|---|
Size (kb) | 71 | 75.713 | − | 69 | − |
pirA | − | + | − | + | − |
pirB | Truncated (nt 361–1317) | + | − | + | + |
Deletion/Insertion | Deletion | Insertion | − | − | Insertion |
Mortality (%) | 0% | 0% | 0% | 100% | 47% |
*: Taken from Phiwsaiya et al., 2017 [14].
Using the same set of primers used for the DNA-PCR assay, the RT-PCR assay successfully amplified both pirA and pirB genes using total RNA from overnight cultures of R14 but not the R13 strain, indicating that the binary toxin genes are transcribed in R14 but not in R13. Duplex RT-PCR also detected both pirA and pirB genes in the reference strain A3.
The R13 strain has a deletion at nucleotide positions 16,103 to 17,910, corresponding to the pVPA3-1 plasmid. The deletion represented the promoter sequence upstream of pirA, the complete pirA coding-sequence and the 5’-portion of pirB coding sequence (nucleotide position 1–364 at the 5’-end of the pirB gene). Because of this deletion, the pirAB genes are not transcribed, and consequently, no cDNA product was detected (Figure 5).
In the R14 strain, a 1058 bp insertion was observed 59 bp upstream of the start codon of the pirA gene. This represented an insertion sequence 5 (IS5) class of sequence elements [22]. It codes for a transposase enzyme that is required for DNA transposition. The A3 strain plasmid (pVPA3-1) carries two of these IS5 elements, one at nucleotide position 15,046 to 16,099 (right to left orientation of the element based on transposase gene position orientation) and a second one at position 19,527 to 20,581 (left to right orientation of the element). The R14 strain carries three copies of the IS5 element: one copy at the position of 64,568 to 65,622 (right to left orientation), a second one at the position of 70,113 to 71,169 (left to right orientation), and the third copy at position 66,662 to 67,718 (left to right orientation) (Figure 7). The third position insertion is surrounded by a 5 bp direct repeat of ATTGA at both ends of the insertion. Such direct repeats of small sequences at both ends (here, a 5 bp fragment) are a landmark of the IS element insertion. This insertion is located at −58 compared to the transcription initiation codon of the pirAB gene block. This insertion disrupts the normal position of transcription elements of native pVPa3-1 plasmid due to addition of an extra 1054 bp IS5 element in pVpR14_74Kb plasmid of R14. However, the insertion did not disrupt the transcription since both pirA and pirB were detected by RT-PCR (Figure 5).
The promoter region (634 bp) of A3 and R14 was compared with BPROM software of softberry suite. The A3 promoter contains phoB, carP, argR and ompR transcription factors’ binding sites which are absent in case of the R14 promoter. The phoB transcription factor is involved in Vibrio cholerae virulence and phosphate starvation [23]. The ompR regulates osmotic stress in Escherichia coli via outer membrane porins [24] (Figure 7).
3.5. Detection of Binary Toxin by Western Blot Analysis
Using PirA and PirB polyclonal antibodies, both PirA and PirB toxins were detected in the reference strain A3 and were not detected in the R13, ATCC and R14 strains. (Figure 8a,b). The results confirmed that the binary toxin is only expressed in the V. parahaemolyticus reference strain A3. The toxins are not expressed in R13 and R14 strains, despite the fact that both pirA and pirB transcripts were detected in R14 by RT-PCR.
4. Discussion
In this study, we found two mutant non-pathogenic strains of V. parahaemolyticus, R13 and R14, that harbor the pVA3 plasmid and contain either pirA or both pirAB genes but did not cause mortality in shrimp in a laboratory experimental challenge. These findings have important implications for AHPND diagnosis since detection of the pirA and pirB genes alone is insufficient to identify AHPND-causing Vibrio spp. Using RT-PCR, it was determined that the R13 strain did not produce pirAB mRNA while R14 did produce mRNA for both pirA and pirB genes, although no toxin protein was detected by Western blot analyses. Han and colleagues [10] proposed a classification scheme to categorize VPAHPND strains based on the presence or absence of the pirA and pirB genes. Bacteria that carry both toxin genes and cause AHPND are categorized as Type I, while those that carry either of the toxin genes and do not cause AHPND are categorized as Type II. Based on this classification scheme, the R13 mutant fits into the Type II category. However, the R14 strain does not meet the criteria for either Type I or Type II mutants since it contains both pirA and pirB genes without causing AHPND. Therefore, in order to accommodate a unique mutant, such as the R14 strain, we propose, here, a new group of mutants—Type III. This class of mutant contains the entire coding regions of both pirA and pirB genes and contains insertion(s) within or just outside the Open reading frame (ORF) of these genes that make the corresponding strain non-pathogenic. Interestingly, the insertion detected in the R14 strain is unique in that it did not affect the transcription of the cognate mRNA but inhibited translation of PirAB proteins. Hence, this strain did not cause mortality in P. vannamei shrimp in the experimental challenge. Only the V. parahaemolyticus reference strain (A3) produced PirA and PirB toxins and caused AHPND in the experimental challenge. It was reported that in order to cause AHPND, both components of the binary toxin pirAB are needed. Sirikharin et al. [13] were able to produce AHPND with 100% mortality only when both recombinant PirA and PirB proteins were injected into P. vannamei shrimp at 10 µg/g of shrimp. However, when each of these proteins was injected separately, AHPND could not be reproduced in shrimp. We conclude that in R13, the deletions of the pirA gene disrupt the expression of the corresponding toxin and, therefore, this strain cannot produce the binary toxin needed to cause AHPND. However, the strain R14 is unique in being able to express the pirAB genes, yet it does not produce a functional toxin that cause lesions characteristic of AHPND in shrimp. It is known that translation in bacteria can be disrupted due to several factors. For example, in Escherichia coli and Bacillus subtilis, mRNA can be destabilized by mutations in the transcript which interfere ribosome binding resulting in translational disruption [25,26,27]. In E. coli, the translation can also be disrupted by uncoupling transcription and translation in which the coding region is exposed to RNase. Typically, ribosome translates mRNA at a speed which is similar to the speed of transcription [28]. Therefore, the nascent transcript carry several ribosomes closely behind the T7-RNA polymerase [29]. Occasionally, T7-RNA polymerase synthesizes mRNA at a speed which is several fold of ribosome speed, thereby uncovering mRNA which is exposed to RNase and cleaved by RNase, resulting in a pause in translation [30]. Alternatively, the translation can be incomplete if ribosome is stalled due to termination of transcription before terminal codon [31,32], existence of a rare codon [33], amino acid starvation [34,35] and the presence of the sequence resulting in the elongation factor being arrested [36]. We do not know if any of these mechanisms are functional in R14 causing translational inhibition.
Insertion sequences (IS) are among the simplest mobile genetic elements. They can move within a genome (within a single DNA molecule or between different DNA molecules) or horizontally between genomes via phages and plasmids. IS-mediated gene regulation affects virulence, microbial resistance and metabolism of the host genome. IS-mediated inactivation of the host gene occurs when it is inserted in a coding sequence of the gene or in the promoter region of the corresponding gene [37]. For example, in Staphylococcus aureus, IS256-mediated modulation of virulence has been reported by insertion into rot (repressor of toxins) promoter [38]. Recently, Phiwsaiya et al. [14] isolated a V. parahaemolyticus isolate, XN87, that tested negative by PCR for pirA gene but carried pirB. Sequence analysis revealed that the plasmid carrying toxin genes in XN87 contained an out-of-frame insertion of a transposon gene in pirA that caused a 2-base reading frameshift in the remainder of the pirA and in the downstream pirB gene sequence (Figure 6). RT-PCR assay showed that bicistronic pirAB mRNA is not produced, and in Western blot analysis, neither toxins were detected. However, in experimental immersion challenge, a 47% mortality rate was recorded in P. vannamei shrimp without any pathognomonic lesions characteristic of AHPND.
5. Conclusions
Some V. parahaemolyticus isolates carry mutant pVA plasmids that produce no PirAB toxins and cause no mortality in experimental challenges using SPF shrimp. We do not know the molecular mechanism of translational inhibition in R14 strain, and future studies will focus on elucidating the yet unknown mechanism of translational inhibition. The phoB and ompR transcription factors binding to the A3 promoter may increase virulence and preferential osmotic survival in A3 compared to R14 where these transcription factors are absent. Despite the unknown reason for the lack of binary toxin production in R14, the current finding highlights the fact that PCR-based detection alone cannot identify AHPND causing V. parahaemolyticus strains unequivocally, and PCR-based diagnostics of AHPND-positive cases need to be confirmed by a bioassay, histopathology and detection of functional binary toxins, a true predictor of AHPND.
Acknowledgments
The authors would like to thank Jasmine Millabas for providing technical assistance in preparing histology slides and Patharapol Piamsomboon for bacterial isolation.
Author Contributions
A.K.D. conceptualized the study, wrote the manuscript and provided full project oversight. L.F.A.C. performed the bioassay, carried out the histopathology and contributed to writing the manuscript. H.N.M. contributed to the bioassay, PCR detection work and Western blot analyses. S.K. conducted the cloning, sequencing and sequence analyses. R.C.-F. supported in the sequence analyses and in writing the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding
Funding for this research was provided by the College of Agriculture and Life Sciences in the University of Arizona to A.K.D. Partial funding for this work was also provided by the U.S department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA), Animal Health Project 1006512 to A.K.D.
Conflicts of Interest
The authors declare no competing interests.
References
- 1.Lightner D., Flegel T. Diseases of Crustaceans–Acute Hepatopancreatic Necrosis Syndrome (AHPNS) (Disease Card). Asia Pacific Emergency Regional Consultation on Early Mortality Syndrome (EMS)/Acute Hepatopancreatic Necrosis Syndrome (AHPNS) 2014.
- 2.Tran L., Nunan L., Redman R., Mohney L., Pantoja C., Fitzsimmons K., Lightner D. Determination of the infectious nature of the agent of acute hepatopancreatic necrosis syndrome affecting penaeid shrimp. Dis. Aquat. Organ. 2013;105:45–55. doi: 10.3354/dao02621. [DOI] [PubMed] [Google Scholar]
- 3.De la Peña L., Cabillon N., Catedral D., Amar E., Usero R., Monotilla W., Calpe A., Fernandez D., Saloma C. Acute hepatopancreatic necrosis disease (AHPND) outbreaks in Penaeus vannamei and P. monodon cultured in the Philippines. Dis. Aquat. Organ. 2015;116:251–254. doi: 10.3354/dao02919. [DOI] [PubMed] [Google Scholar]
- 4.Nunan L., Lightner D., Pantoja C., Gomez-Jimenez S. Detection of acute hepatopancreatic necrosis disease (AHPND) in Mexico. Dis. Aquat. Organ. 2014;111:81–86. doi: 10.3354/dao02776. [DOI] [PubMed] [Google Scholar]
- 5.Dhar A.K., Piamsomboon P., Aranguren Caro L.F., Kanrar S., Adami R., Juan Y.-S. First report of acute hepatopancreatic necrosis disease (AHPND) occurring in the USA. Dis. Aquat. Organ. 2019;132:241–247. doi: 10.3354/dao03330. [DOI] [PubMed] [Google Scholar]
- 6.Woo J., Eun J., Tang K.F.J., Lightner D.V., Kim J., Won S., Chang S. Potential application of bacteriophage pVp-1: Agent combating Vibrio parahaemolyticus strains associated with acute hepatopancreatic necrosis disease ( AHPND ) in shrimp. Aquaculture. 2016;457:100–103. [Google Scholar]
- 7.Restrepo L., Bayot B., Betancourt I., Pinzón A. Draft genome sequence of pathogenic bacteria Vibrio parahaemolyticus strain Ba94C2, associated with acute hepatopancreatic necrosis disease isolate from South America. Genomics Data. 2016;9:143–144. doi: 10.1016/j.gdata.2016.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Restrepo L., Bayot B., Arciniegas S., Bajaña L., Betancourt I., Panchana F., Reyes Muñoz A. PirVP genes causing AHPND identified in a new Vibrio species (Vibrio punensis) within the commensal Orientalis clade. Sci. Rep. 2018;8:13080. doi: 10.1038/s41598-018-30903-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Han J., Tang K., Lightner D. Genotyping of virulence plasmid from Vibrio parahaemolyticus isolates causing acute hepatopancreatic necrosis disease in shrimp. Dis. Aquat. Organ. 2015;115:245–251. doi: 10.3354/dao02906. [DOI] [PubMed] [Google Scholar]
- 10.Han J.E., Tang K.F.J., Aranguren L.F., Piamsomboon P. Characterization and pathogenicity of acute hepatopancreatic necrosis disease natural mutants, pirABvp (-) V. parahaemolyticus, and pirABvp (+) V. campbellii strains. Aquaculture. 2017;470:84–90. doi: 10.1016/j.aquaculture.2016.12.022. [DOI] [Google Scholar]
- 11.Kondo H., Van P.T., Dang L.T., Hirono I. Draft Genome Sequence of Non- Vibrio parahaemolyticus Acute Hepatopancreatic Necrosis Disease Strain KC13.17.5, Isolated from Diseased Shrimp in Vietnam. Genome Announc. 2015;3:2014–2015. doi: 10.1128/genomeA.00978-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Xiao J., Liu L., Ke Y., Li X., Liu Y., Pan Y., Yan S., Wang Y. Shrimp AHPND-causing plasmids encoding the PirAB toxins as mediated by pirAB-Tn903 are prevalent in various Vibrio species. Sci. Rep. 2017;7:42177. doi: 10.1038/srep42177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Sirikharin R., Taengchaiyaphum S., Sanguanrut P., Chi T.D., Mavichak R., Proespraiwong P., Nuangsaeng B., Thitamadee S., Flegel T.W., Sritunyalucksana K. Characterization and PCR Detection Of Binary, Pir-Like Toxins from Vibrio parahaemolyticus Isolates that Cause Acute Hepatopancreatic Necrosis Disease (AHPND) in Shrimp. PLoS ONE. 2015;10:e0126987. doi: 10.1371/journal.pone.0126987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Phiwsaiya K., Charoensapsri W., Taengphu S., Dong H.T., Sangsuriya P., Taengchaiyaphum S., Chaivisuthangkura P., Longyant S., Sithigorngul P., Senapin S. A Natural Vibrio parahaemolyticus Produces neither Pir Vp Toxins nor Acute Hepatopancreatic Necrosis Disease. Appl. Environ. Microbiol. 2017;83:1–15. doi: 10.1128/AEM.00680-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Fernando L., Caro A., Mai H.N., Noble B., Dhar A.K. Acute hepatopancreatic necrosis disease (VP AHPND), a chronic disease in shrimp Penaeus vannamei population raised in latin America. J. Invertebr. Pathol. 2020;174:107424. doi: 10.1016/j.jip.2020.107424. [DOI] [PubMed] [Google Scholar]
- 16.Weisburg W.G., Barns S.M., Pelletier D.A., Lane D.J. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 1991;173:697–703. doi: 10.1128/JB.173.2.697-703.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kim Y.B., Okuda J., Matsumoto C., Takahashi N., Hashimoto S., Nishibuchi M. Identification of Vibrio parahaemolyticus strains at the species level by PCR targeted to the toxR gene. J. Clin. Microbiol. 1999;37:1173–1177. doi: 10.1128/JCM.37.4.1173-1177.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Han J., Tang K., Tran L., Lightner D. Photorhabdus insect-related (Pir) toxin-like genes in a plasmid of Vibrio parahaemolyticus, the causative agent of acute hepatopancreatic necrosis disease (AHPND) of shrimp. Dis. Aquat. Organ. 2015;113:33–40. doi: 10.3354/dao02830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bell T.A., Lightner D.V. A Handbook of Normal Penaeid Shrimp Histology. 1st ed. World Aquaculture Society; Baton Rouge, Louisiana: 1988. [Google Scholar]
- 20.Mai H.N., Cruz-Flores R., Dhar A.K. Development of an indirect Enzyme Linked Immunoassay (iELISA) using monoclonal antibodies against Photorhabdus insect related toxins, PirAVp and PirBVp released from Vibrio spp. J. Microbiol. Methods. 2020;176:106002. doi: 10.1016/j.mimet.2020.106002. [DOI] [PubMed] [Google Scholar]
- 21.Kanrar S., Dhar A.K. Complete Genome Sequence of a Novel Mutant Strain of Vibrio parahaemolyticus from Pacific White Shrimp (Penaeus vannamei) Genome Announc. 2018;6:19–20. doi: 10.1128/genomeA.00497-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Siguier P., Gourbeyre E., Chandler M. Bacterial insertion sequences: Their genomic impact and diversity. FEMS Microbiol. Rev. 2014;38:865–891. doi: 10.1111/1574-6976.12067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pratt J.T., Ismail A.M., Camilli A. PhoB regulates both environmental and virulence gene expression in Vibrio cholerae. Mol. Microbiol. 2010;77:1595–1605. doi: 10.1111/j.1365-2958.2010.07310.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Seo S.W., Gao Y., Kim D., Szubin R., Yang J., Cho B.-K., Palsson B.O. Revealing genome-scale transcriptional regulatory landscape of OmpR highlights its expanded regulatory roles under osmotic stress in Escherichia coli K-12 MG1655. Sci. Rep. 2017;7:2181. doi: 10.1038/s41598-017-02110-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Arnold T.E., Yu J., Belasco J.G. mRNA stabilization by the ompA 5’ untranslated region: Two protective elements hinder distinct pathways for mRNA degradation. RNA. 1998;4:319–330. [PMC free article] [PubMed] [Google Scholar]
- 26.Wagner L.A., Gesteland R.F., Dayhuff T.J., Weiss R.B. An efficient Shine-Dalgarno sequence but not translation is necessary for lacZ mRNA stability in Escherichia coli. J. Bacteriol. 1994;176:1683–1688. doi: 10.1128/JB.176.6.1683-1688.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Karhumaa K., Rutberg B., Hambraeus G. A 5′ stem–loop and ribosome binding but not translation are important for the stability of Bacillus subtilis aprE leader mRNA. Microbiology. 2002;148:1795–1803. doi: 10.1099/00221287-148-6-1795. [DOI] [PubMed] [Google Scholar]
- 28.Epshtein V., Nudler E. Cooperation Between RNA Polymerase Molecules in Transcription Elongation. Science (80-. ) 2003;300:801–805. doi: 10.1126/science.1083219. [DOI] [PubMed] [Google Scholar]
- 29.Deana A. Lost in translation: The influence of ribosomes on bacterial mRNA decay. Genes Dev. 2005;19:2526–2533. doi: 10.1101/gad.1348805. [DOI] [PubMed] [Google Scholar]
- 30.Iost I., Dreyfus M. The stability of Escherichia coli lacZ mRNA depends upon the simultaneity of its synthesis and translation. EMBO J. 1995;14:3252–3261. doi: 10.1002/j.1460-2075.1995.tb07328.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Abo T., Inada T., Ogawa K., Aiba H. SsrA-mediated tagging and proteolysis of LacI and its role in the regulation of lac operon. EMBO J. 2000;19:3762–3769. doi: 10.1093/emboj/19.14.3762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kobayashi K., Kuwana R., Takamatsu H. kinA mRNA is missing a stop codon in the undomesticated Bacillus subtilis strain ATCC 6051. Microbiology. 2008;154:54–63. doi: 10.1099/mic.0.2007/011783-0. [DOI] [PubMed] [Google Scholar]
- 33.Roche E.D., Sauer R.T. SsrA-mediated peptide tagging caused by rare codons and tRNA scarcity. EMBO J. 1999;18:4579–4589. doi: 10.1093/emboj/18.16.4579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Li X., Yagi M., Morita T., Aiba H. Cleavage of mRNAs and role of tmRNA system under amino acid starvation in Escherichia coli. Mol. Microbiol. 2008;68:462–473. doi: 10.1111/j.1365-2958.2008.06167.x. [DOI] [PubMed] [Google Scholar]
- 35.Garza-Sánchez F., Gin J.G., Hayes C.S. Amino Acid Starvation and Colicin D Treatment Induce A-site mRNA Cleavage in Escherichia coli. J. Mol. Biol. 2008;378:505–519. doi: 10.1016/j.jmb.2008.02.065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Sunohara T., Jojima K., Tagami H., Inada T., Aiba H. Ribosome Stalling during Translation Elongation Induces Cleavage of mRNA Being Translated in Escherichia coli. J. Biol. Chem. 2004;279:15368–15375. doi: 10.1074/jbc.M312805200. [DOI] [PubMed] [Google Scholar]
- 37.Strauß L., Stegger M., Akpaka P.E., Alabi A., Breurec S., Coombs G., Egyir B., Larsen A.R., Laurent F., Monecke S., et al. Origin, evolution, and global transmission of community-acquired Staphylococcus aureus ST. Proc. Natl. Acad. Sci. USA. 2017;114:E10596–E10604. doi: 10.1073/pnas.1702472114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Benson M.A., Ohneck E.A., Ryan C., Alonzo F., Smith H., Narechania A., Kolokotronis S.-O., Satola S.W., Uhlemann A.-C., Sebra R., et al. Evolution of hypervirulence by a MRSA clone through acquisition of a transposable element. Mol. Microbiol. 2014;93:664–681. doi: 10.1111/mmi.12682. [DOI] [PMC free article] [PubMed] [Google Scholar]